Liminal BioSciences Inc.
Liminal BioSciences Inc. (LMNL) Revenue
Annual & quarterly revenue history · segment & region breakdown
LMNL · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsLiminal BioSciences Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Liminal BioSciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Liminal BioSciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Liminal BioSciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LMNL revenue · 4 questionsLMNL's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Liminal BioSciences Inc. SEC filings · GAAP · Liminal BioSciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026